Prohibitin 3' untranslated region polymorphism and breast cancer risk.
Campbell
Ian G
IG
VBCRC Cancer Genetics Laboratory, Centre for Cancer Genomics and Predictive Medicine, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne, Victoria, Australia. i.campbell@pmci.unimelb.edu.au
Allen
James
J
Eccles
Diana M
DM
D020413:3' Untranslated Regions; D000293:Adolescent; D017668:Age of Onset; D000970:Antineoplastic Agents; D001943:Breast Neoplasms / Q000209:etiology* / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D016017:Odds Ratio; D010375:Pedigree; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D000091402:Prohibitins; D011506:Proteins; D012097:Repressor Proteins; D012307:Risk Factors
D020413:3' Untranslated Regions; D000970:Antineoplastic Agents; D000091402:Prohibitins; D011506:Proteins; D012097:Repressor Proteins